Noncontrast Computed Tomography Markers as Predictors of Revised Hematoma Expansion in Acute Intracerebral Hemorrhage.
Wen‐Song Yang,Shu‐Qiang Zhang,Yi‐Qing Shen,Xiao Wei,Li‐Bo Zhao,Xiong‐Fei Xie,Lan Deng,Xin‐Hui Li,Xin‐Ni Lv,Fa‐Jin Lv,Dar Dowlatshahi,Qi Li,Peng Xie
DOI: https://doi.org/10.1161/jaha.120.018248
IF: 6.106
2021-01-30
Journal of the American Heart Association
Abstract:Background Noncontrast computed tomography (NCCT) markers are the emerging predictors of hematoma expansion in intracerebral hemorrhage. However, the relationship between NCCT markers and the dynamic change of hematoma in parenchymal tissues and the ventricular system remains unclear. Methods and Results We included 314 consecutive patients with intracerebral hemorrhage admitted to our hospital from July 2011 to May 2017. The intracerebral hemorrhage volumes and intraventricular hemorrhage (IVH) volumes were measured using a semiautomated, computer‐assisted technique. Revised hematoma expansion (RHE) was defined by incorporating the original definition of hematoma expansion into IVH growth. Receiver operating characteristic curve analysis was used to compare the performance of the NCCT markers in predicting the IVH growth and RHE. Of 314 patients in our study, 61 (19.4%) had IVH growth and 93 (23.9%) had RHE. After adjustment for potential confounding variables, blend sign, black hole sign, island sign, and expansion‐prone hematoma could independently predict IVH growth and RHE in the multivariate logistic regression analysis. Expansion‐prone hematoma had a higher predictive performance of RHE than any single marker. The diagnostic accuracy of RHE in predicting poor prognosis was significantly higher than that of hematoma expansion. Conclusions The NCCT markers are independently associated with IVH growth and RHE. Furthermore, the expansion‐prone hematoma has a higher predictive accuracy for prediction of RHE and poor outcome than any single NCCT marker. These findings may assist in risk stratification of NCCT signs for predicting active bleeding. Nonstandard Abbreviations and Acronyms ATACH‐2 Antihypertensive Treatment of Acute Cerebral Hemorrhage 2 EPH expansion‐prone hematoma NCCT noncontrast computed tomography RHE revised hematoma expansion Clinical Perspective What Is New? We have investigated whether the noncontrast computed tomography markers could predict the intraventricular hemorrhage growth and revised hematoma expansion criteria, which has not been reported in previous studies. We tested the diagnostic performance of noncontrast computed tomography markers in predicting intraventricular hemorrhage growth and revised hematoma expansion criteria, and found that noncontrast computed tomography markers are independently associated with intraventricular hemorrhage growth and revised hematoma expansion. The expansion‐prone hematoma has a higher predictive accuracy for predicting revised hematoma expansion and poor outcome than any single noncontrast computed tomography marker. What Are the Clinical Implications? Our findings may assist in the risk stratification of active bleeding, and be helpful for providing more accurate prognostic information for clinical decision‐making. Our results may help clinicians to select patients for antiexpansion treatment in future clinical trials. Intracerebral hemorrhage (ICH) accounts for 8% to 27% of all strokes and leads to high mortality and morbidity worldwide. 1 The mortality of patients with ICH ranges from 35% at 7 days to 59% at 1 year, and >60% of survivors are left with severe functional disability. 2 Hematoma expansion (HE) occurs in ≈30% of patients with ICH 3 , 4 and is considered as a potentially modifiable predictor target for antiexpansion treatment in many clinical trials. 5 , 6 , 7 , 8 Although several trials have curbed the growth of hematoma, the outcomes of patients have not been improved accordingly. 6 , <a class="tab-link" href="#jah35910 -Abstract Truncated-
cardiac & cardiovascular systems